Yahoo Web Search

Search results

    • Pfizer: An Oversold Pharma Stock in Recovery

      Pfizer: An Oversold Pharma Stock in Recovery

      GuruFocus.com via Yahoo Finance· 7 days ago

      This combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...

    • Gateway - Quartz

      Quartz· 18 hours ago

      Pharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines ...